FirmAtlas
Company handbook · SNPS · Prepared by FirmAtlas · firmatlas.app · printed 2026-10-16
SNPS · CIK 883241 · LATEST FILING: 10-Q JUL '26 · FILED AUG 26, 2026
SYNOPSYS, INC.
$454.63
−13.48 (−2.88%)
Close, Oct 16, 2026 · 52-week $363–539
Synopsys sells software that engineers use to design and test chips (electronic design automation), reusable chip design blocks (IP), and simulation software for products such as cars and planes (from its 2025 purchase of Ansys).
Business
- SegmentsDesign Automation 75% · Design IP 25% (FY25)
- ProductsLicense And Maintenance 49% · License 29% · Technology Service 22% (FY25)
- RegionsUS 44% · South Korea 13% · Europe 13% · China 12% · Other 18% (FY25)
- CustomersChip companies, and makers of electronics, cars, aircraft and other products; sold mostly by its own sales force, often under multi-year licenses
- Cash useFY24–FY25: capex $309M
Reinvested 11% of operating cash flow
Last fiscal year
SYNOPSYS, INC. reported revenue of $7.1B for the year ended Oct 31, 2025 (FY25), up 15.1% from FY24. Net income was $1.3B, operating cash flow $1.5B and free cash flow $1.3B. Source: 10-K filed Dec 22, 2025.
Market cap
$84.6B
P/E
78.5
EV/EBITDA
60.4x
P/B
2.7
ROIC
4.0%
Revenue 1Y
15.1%/yr
EPS 1Y
−44.6%/yr
Shares 1Y
+21%
Loading chart…
Median
Daily closes, split-adjusted · ratios at each fiscal year end
Company
CEOSassine Ghazi
HQSunnyvale, CA
AuditorKPMG LLP
Employees28,000
Year endsOctober
Revenue by segment · FY25
Design Automation75%
Design IP25%
Compounded growth & averages
10Y
5Y
3Y
TTM
Share price
22.5%
8.2%
−2.6%
3.3%
Upgrade to see 10 years
Share price: yearly compound rate of the traded close; the last column is the past year.
Where the cash went · FY24–FY25
$309M deployed
Capex
$309M
100.0%
Operating cash flow over the period: $2.9B. Total debt changed by +$13.5B. R&D of $4.6B is already inside operating costs.
Growth engines
How much of the profit growth came from new investment, and how much from running the business better.
Upgrade to see 10 years
Financials
Last 2 years · Upgrade to see 10 years · USD millions · each year opens its 10-K · FY25 = year ended Oct 31, 2025 · change vs previous year
Last 4 quarters · USD millions · quarter-end month shown · change vs same quarter a year earlier
TTM = the last four quarters, to Jul '26. Balance-sheet rows show that latest quarter. “—” where the quarters do not add up to the annual figures. No TTM for cash: our quarterly rows do not hold short-term investments yet, and annual cash includes them.
Income
Revenue
6,127
7,054+15.1%
9,416
YoY
+15.1%
Gross profit
4,882
5,431+11.2%
6,815
Gross margin
79.7%
77.0%−2.7 pp
—
Operating income
1,356
915−32.5%
802
Operating margin
22.1%
13.0%−9.2 pp
—
EBITDA
1,651
1,575−4.6%
—
EBITDA margin
26.9%
22.3%−4.6 pp
—
Interest expense
37
447+1113.0%
—
Interest coverage
44.82x
3.53x−41.30x
—
Net income
2,263
1,332−41.1%
1,077
YoY
−41.1%
Net margin
36.9%
18.9%−18.1 pp
—
EPS (diluted, $)
14.51
8.04−44.6%
5.68
YoY
−44.6%
Balance sheet
Total assets
13,074
48,224+268.9%
47,726
Cash & short-term investments
4,050
2,961−26.9%
—
Accounts receivable
934
1,505+61.1%
—
Inventory
362
365+0.9%
—
Net PP&E
563
697+23.7%
—
Other assets
7,164
42,696+496.0%
—
Total liabilities
4,083
19,897+387.3%
16,574
Accounts payable
207
165−20.5%
—
Total debt
16
13,507+86475.4%
11,058
Other liabilities
3,860
6,225+61.3%
—
Shareholders’ equity
8,991
28,328+215.1%
31,153
Total liabilities = total assets − shareholders’ equity, so it includes minority interest where a company has one.
Cash flow statement · as filed
Cash from operations
1,407
1,519+7.9%
2,938
Net income
2,236
1,333−40.4%
—
Depreciation & amortization
295
660+123.8%
—
Stock-based compensation
692
893+29.0%
—
Working capital & other
(1,816)
(1,368)n/m
—
Cash from investing
1,223
(15,881)−1398.5%
—
Capex
(140)
(169)n/m
—
PP&E sold
16
74+354.6%
—
Investments bought
(137)
(66)n/m
—
Investments sold / matured
139
157+13.1%
—
Other investing
1,344
(15,878)−1281.3%
—
Cash from financing
(181)
13,356n/m
—
Debt raised
0
14,329n/m
—
Debt repaid
(3)
(864)n/m
—
Buybacks
0
0n/m
—
Other financing
(179)
(110)n/m
—
Net change in cash
2,458
(1,005)−140.9%
—
Free cash flow (OCF − capex)
1,268
1,349+6.4%
2,748
Where the cash went
Operating cash flow
1,407
1,519+7.9%
2,938
Reinvested in the business
140
169+21.5%
—
% of operating cash flow
9.9%
11.2%
Capex
140
169+21.5%
191
R&D (memo, already in costs)
2,082
2,479+19.1%
—
Free cash flow
1,268
1,349+6.4%
2,748
YoY
+6.4%
Returned to shareholders
0
0n/m
—
% of free cash flow
0.0%
0.0%
Buybacks
0
0n/m
—
Change in total debt
—
13,491
—
Cash left over
—
14,840
—
FCF conversion (FCF ÷ net income)
56.0%
101.3%+45.3 pp
—
Owner earnings
—
1,206
—
Owner earnings margin
—
17.1%
—
Returns & ratios
ROIC (all capital)
25.6%
4.0%−21.5 pp
—
ROIC (operating)
76.7%
43.3%−33.3 pp
—
Net debt / EBITDA
−2.44x
6.69x+9.14x
—
Debt / equity
0.00x
0.48x+0.48x
—
ROE
25.2%
4.7%−20.5 pp
—
ROA
17.3%
2.8%−14.6 pp
—
ROCE
13.0%
2.1%−11.0 pp
—
NOPAT
1,266
878−30.7%
—
Invested capital (operating)
1,652
2,403+45.4%
—
Invested capital (all)
4,956
38,873+684.4%
—
Reinvestment rate
—
85.5%
—
Net debt is 6.7x EBITDA (FY25).
Income
Oct '25
Jan '26
Apr '26
Jul '26
Revenue
2,255
2,409
2,276
2,477
vs year-ago quarter
Gross profit
1,600
1,771
1,646
1,797
Gross margin
71.0%
73.5%
72.3%
72.6%
Operating income
121
203
120
357
Net income
449
65
17
546
vs year-ago quarter
Net margin
19.9%
2.7%
0.8%
22.0%
EPS (diluted, $)
2.41
0.34
0.09
2.84
vs year-ago quarter
Balance sheet
Oct '25
Jan '26
Apr '26
Jul '26
Total assets
48,224
47,238
46,889
47,726
Cash & equivalents
2,961
2,203
2,484
3,608
Total debt
13,507
10,066
10,058
11,058
Shareholders’ equity
28,328
30,549
30,478
31,153
Cash flow
Oct '25
Jan '26
Apr '26
Jul '26
Operating cash flow
640
857
629
813
Capex
35
35
54
67
Free cash flow
605
822
575
746
vs year-ago quarter